A newly patented technology developed as a collaboration in the departments of Biomedical Engineering, Orthopaedics, and Microbiology and Immunology is at the heart of an Office of Naval Research (ONR) grant focused on preventing and treating orthopaedic implant-related infections.
A global study led by Paresh Dandona, MD, PhD, found a majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels.
Daniel J. Kosman, PhD, SUNY Distinguished Professor of biochemistry, has been awarded a five-year, $1.96 million grant that may lead to advances in understanding the progression of Alzheimer’s disease.
Researchers in the Department of Medicine have published a study that identifies a new way to predict which patients may be at a higher risk for heart failure after undergoing Transcatheter Aortic Valve Implantation (TAVR).
Umesh Sharma, MD, PhD, assistant professor of medicine, has received a five-year, $1 million grant from the National Institutes of Health (NIH) to study galectin-3, a protein involved in heart failure.
Researchers in the Department of Pharmacology and Toxicology have developed and successfully tested a method for determining whether promising new multiple sclerosis (MS) treatments in mice could be effective in humans.
The cranes are long gone from the new home of the Jacobs School of Medicine and Biomedical Sciences. So is the industrial elevator, or “buck hoist,” that carried workers up and down the outside of the building. Nearly all 27,000-plus locally produced terra cotta panels that give the building’s outer shell a distinctive, clay-colored skin have been installed.
Allen Hoste, working under the guidance of mentor Tracey A. Ignatowski, PhD, assistant professor of pathology and anatomical sciences, tied for first place in the undergraduate poster award at the New York Pharmacology Society (NYPS) sixth annual scientific meeting.